Printer Friendly

AMEX BEGINS TRADING OPTIONS ON MEDCO RESEARCH STOCK

 AMEX BEGINS TRADING OPTIONS ON MEDCO RESEARCH STOCK
 NEW YORK, Nov. 26 /PRNewswire/ -- The American Stock Exchange today


opened put and call options trading in the listed stock of Medco Research, Inc. (ticker symbol: MRE).
 Headquartered in Los Angeles, Medco Research develops new prescription drugs used primarily in the treatment and diagnosis of cardiovascular diseases.
 MRE opened with strike prices of 20, 22 1/2, and 25, and position limits of 3,000 contracts. Initial expiration months are December of 1991 and January, April, and July of 1992. Cohen, Cohn, Duffy & McGowan, Inc./Aegis & Co. is the specialist unit for the new options.
 The Amex trades a total of 253 stock options, including 68 options on over-the-counter stocks. In addition, options are traded on four broad market indexes -- the Major Market Index (XMI), the LT-20 Index (XLT), the Institutional Index (XII) and the Japan Index (JPN) -- as well as two industry-based indexes -- the Oil Index (XOI) and the Computer Technology Index (XCI). CAPS -- capped options -- are traded on XMI and XII as well. The exchange also trades 22 long-term options on leading stocks which have expirations up to almost three years.
 -0- 11/26/91
 /CONTACT: Shelly Wolfe of Amex, 212-306-1641/
 (MRE) CO: Medco Research, Inc. ST: California IN: MTC SU: KD -- NY055 -- 7340 11/26/91 13:31 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 26, 1991
Words:220
Previous Article:IBM ANNOUNCES ACTIONS TO FURTHER STREAMLINE COMPANY; OUTLINES PLANS TO INCREASE INDEPENDENCE OF BUSINESS UNITS
Next Article:HUNTINGTON BANKS' NEW BAND ORGAN TO DEBUT
Topics:


Related Articles
MEDCO RESEARCH TO RELOCATE OPERATIONS
MEDCO RESEARCH REPORTS FIRST QUARTER FINANCIAL RESULTS
MEDCO RESEARCH REPORTS REACTIVATION OF STOCK REPURCHASE PROGRAM
AMEX TO TRADE OPTIONS ON AGOURON PHARMACEUTICALS, INC. AND SAFEGUARD SCIENTIFICS, INC. BEGINNING NEXT WEEK
MEDCO RESEARCH RETAINS OPPENHEIMER & CO., INC. AS INVESTMENT BANKER
Medco Research Authorizes 500,000 Share Increase In Stock Repurchase Program
AMEX to Trade Options on Medco Health Solutions, Inc.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters